Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

Source:http://linkedlifedata.com/resource/pubmed/id/10915163

Download in:

View as

General Info

PMID
10915163